A detailed history of Pinnacle Associates LTD transactions in Renalytix PLC stock. As of the latest transaction made, Pinnacle Associates LTD holds 846,534 shares of RNLX stock, worth $126,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
846,534
Previous 815,425 3.82%
Holding current value
$126,980
Previous $187,000 5.35%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$0.21 - $0.45 $6,532 - $13,999
31,109 Added 3.82%
846,534 $177,000
Q2 2024

Jul 30, 2024

BUY
$0.23 - $0.93 $27,466 - $111,060
119,420 Added 17.16%
815,425 $187,000
Q1 2024

Apr 26, 2024

SELL
$0.26 - $1.47 $39,137 - $221,277
-150,529 Reduced 17.78%
696,005 $598,000
Q4 2023

Jan 19, 2024

BUY
$0.33 - $1.61 $19,988 - $97,520
60,572 Added 7.71%
846,534 $330,000
Q3 2023

Oct 23, 2023

SELL
$1.51 - $4.01 $80,573 - $213,973
-53,360 Reduced 6.36%
785,962 $1.26 Million
Q2 2023

Jul 26, 2023

BUY
$2.0 - $2.92 $65,050 - $94,973
32,525 Added 4.03%
839,322 $2.45 Million
Q1 2023

May 04, 2023

BUY
$1.93 - $3.72 $447,790 - $863,099
232,016 Added 40.37%
806,797 $1.95 Million
Q4 2022

Jan 31, 2023

BUY
$1.06 - $2.21 $107,489 - $224,105
101,405 Added 21.42%
574,781 $1.07 Million
Q4 2022

Jan 25, 2023

BUY
$1.06 - $2.21 $21,465 - $44,752
20,250 Added 4.47%
473,376 $0
Q3 2022

Oct 31, 2022

BUY
$1.19 - $2.78 $134,339 - $313,834
112,890 Added 33.18%
453,126 $580,000
Q2 2022

Aug 02, 2022

BUY
$2.45 - $7.81 $86,710 - $276,411
35,392 Added 11.61%
340,236 $834,000
Q1 2022

May 05, 2022

BUY
$5.88 - $15.9 $675,141 - $1.83 Million
114,820 Added 60.42%
304,844 $2.11 Million
Q4 2021

Feb 02, 2022

BUY
$13.43 - $27.4 $16,586 - $33,839
1,235 Added 0.65%
190,024 $3.02 Million
Q3 2021

Oct 19, 2021

BUY
$17.91 - $34.78 $1.23 Million - $2.4 Million
68,904 Added 57.48%
188,789 $3.79 Million
Q2 2021

Aug 02, 2021

BUY
$23.56 - $34.25 $516,058 - $750,212
21,904 Added 22.36%
119,885 $3.7 Million
Q1 2021

May 12, 2021

BUY
$15.25 - $31.13 $969,000 - $1.98 Million
63,541 Added 184.5%
97,981 $2.51 Million
Q4 2020

Jan 26, 2021

BUY
$10.69 - $16.0 $104,762 - $156,800
9,800 Added 39.77%
34,440 $551,000
Q3 2020

Oct 23, 2020

BUY
$10.18 - $17.3 $250,835 - $426,272
24,640 New
24,640 $300,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.